P.M. Mrozikiewicz

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population

Elena A. Gaikovitch, Ingolf Cascorbi, P.M. Mrozikiewicz et al. · European Journal of Clinical Pharmacology · 2003 · 237 citations

Medicine, Pharmacokinetics, Pharmacology +14

Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain

Marcin Ożarowski, Anna Bogacz, Agnieszka Gryszczyńska et al. · Fitoterapia · 2013 · 162 citations

Life Sciences, Neuroscience, Pharmacology +16

Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.

Ingolf Cascorbi, J Brockmöller, P.M. Mrozikiewicz et al. · PubMed · 1996 · 139 citations

Medicine, Genetics, Molecular Genetics +9

A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study

Michael Laule, Ingolf Cascorbi, Verena Stangl et al. · The Lancet · 1999 · 85 citations

Medicine, Cardiology, Internal Medicine +14

MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes

Kersti Oselin, Thomas Gerloff, P.M. Mrozikiewicz et al. · Fundamental and Clinical Pharmacology · 2003 · 67 citations

Medicine, Genetics, Molecular Genetics +13